Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Consolidated Net Income: 2012-2025

Historic Consolidated Net Income for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $26.5 million.

  • Phibro Animal Health's Consolidated Net Income rose 280.32% to $26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.1 million, marking a year-over-year increase of 123.38%. This contributed to the annual value of $43.5 million for FY2025, which is 228.61% up from last year.
  • Latest data reveals that Phibro Animal Health reported Consolidated Net Income of $26.5 million as of Q3 2025, which was up 112.71% from $12.5 million recorded in Q2 2025.
  • Over the past 5 years, Phibro Animal Health's Consolidated Net Income peaked at $26.5 million during Q3 2025, and registered a low of -$8.0 million during Q3 2023.
  • Its 3-year average for Consolidated Net Income is $9.3 million, with a median of $8.6 million in 2023.
  • In the last 5 years, Phibro Animal Health's Consolidated Net Income slumped by 307.86% in 2023 and then soared by 280.32% in 2025.
  • Phibro Animal Health's Consolidated Net Income (Quarterly) stood at $17.5 million in 2021, then tumbled by 58.72% to $7.2 million in 2022, then slumped by 82.33% to $1.3 million in 2023, then skyrocketed by 150.00% to $3.2 million in 2024, then skyrocketed by 280.32% to $26.5 million in 2025.
  • Its last three reported values are $26.5 million in Q3 2025, $12.5 million for Q2 2025, and $20.9 million during Q1 2025.